Generalized morphea treated with secukinumab
Ital J Dermatol Venerol
.
2023 Aug;158(4):368-369.
doi: 10.23736/S2784-8671.23.07502-3.
Authors
Angela Filoni
1
,
Domenico Bonamonte
2
,
Adele Civino
3
,
Francesco LA Torre
4
,
Maurizio Congedo
5
Affiliations
1
Section of Dermatology, Vito Fazzi Hospital, Lecce, Italy - angela.filoni@gmail.com.
2
Section of Dermatology, Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.
3
Department of Pediatric Immunology and Rheumatology, Vito Fazzi Hospital, Lecce, Italy.
4
Department of Pediatrics, Giovanni XXIII Pediatric Hospital, Bari, Italy.
5
Section of Dermatology, Vito Fazzi Hospital, Lecce, Italy.
PMID:
37539507
DOI:
10.23736/S2784-8671.23.07502-3
No abstract available
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Scleroderma, Localized* / drug therapy
Scleroderma, Systemic*
Substances
secukinumab
Antibodies, Monoclonal, Humanized